These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25899124)

  • 1. A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin.
    Su J; Iehara M; Yasukawa J; Matsumoto Y; Hamamoto H; Sekimizu K
    J Antibiot (Tokyo); 2015 Oct; 68(10):646-8. PubMed ID: 25899124
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
    Rubio A; Conrad M; Haselbeck RJ; G C K; Brown-Driver V; Finn J; Silverman JA
    Antimicrob Agents Chemother; 2011 Jan; 55(1):364-7. PubMed ID: 20974866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
    Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.
    Yang SJ; Xiong YQ; Dunman PM; Schrenzel J; François P; Peschel A; Bayer AS
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2636-7. PubMed ID: 19289517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
    Mariani PG; Sader HS; Jones RN
    J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
    [No Abstract]   [Full Text] [Related]  

  • 7. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
    Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Mutations Impacting Antibiotic Susceptibility in an Established Staphylococcus aureus Biofilm.
    Atwood DN; Beenken KE; Lantz TL; Meeker DG; Lynn WB; Mills WB; Spencer HJ; Smeltzer MS
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1826-9. PubMed ID: 26824954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA; Smirnova MV; Lubenko IY; Vostrov SN; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2006 Dec; 58(6):1185-92. PubMed ID: 17028094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
    Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective
    Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
    mSphere; 2024 Jun; 9(6):e0011524. PubMed ID: 38752757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
    Cui L; Tominaga E; Neoh HM; Hiramatsu K
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1079-82. PubMed ID: 16495273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus.
    Mechler L; Herbig A; Paprotka K; Fraunholz M; Nieselt K; Bertram R
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5366-76. PubMed ID: 26100694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
    Begic D; von Eiff C; Tsuji BT
    J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
    Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
    J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function.
    Rose WE; Rybak MJ; Tsuji BT; Kaatz GW; Sakoulas G
    J Antimicrob Chemother; 2007 Jun; 59(6):1190-3. PubMed ID: 17434881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
    Friedman L; Alder JD; Silverman JA
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2137-45. PubMed ID: 16723576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial mechanism of daptomycin antibiotic against Staphylococcus aureus based on a quantitative bacterial proteome analysis.
    Ma W; Zhang D; Li G; Liu J; He G; Zhang P; Yang L; Zhu H; Xu N; Liang S
    J Proteomics; 2017 Jan; 150():242-251. PubMed ID: 27693894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
    Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.